Insider Transactions Reported by 10 Insiders of Inhibitor Therapeutics, Inc.

Symbol
INTI on OTC
Location
Tampa, FL

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Inhibitor Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jerman A. Michael Director 01 Apr 2024
Black Robe Capital LLC 10%+ Owner 05 May 2023
Michelle Yanez Director 31 Dec 2024
James A. McNulty Chief Financial Officer 31 Dec 2024
Niraj Vasisht Director 01 Apr 2024
Francis E. Odonnell Jr. Chief Executive Officer, Executive Chairman of the Board, Director, 10%+ Owner 13 Dec 2022
Samuel P. Sears Jr. Director 01 Apr 2024
TPB 2012 LLC 10%+ Owner 05 May 2023
Ronald E. Osman Director, 10%+ Owner 01 Apr 2024
Ronald E Osman Irrevocable Trust III 10%+ Owner 05 May 2023

Recent Insider Transactions by Companies or Individuals for Inhibitor Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Niraj Vasisht INTI Common Stock Award 50,000 $150,000 01 Apr 2025 Direct
Michelle Yanez INTI Common Stock Award 5.91% 50,000 896,271 01 Apr 2025 Direct
Samuel P. Sears Jr. INTI Common Stock Award 4.07% 50,000 1,279,543 01 Apr 2025 Direct
Ronald E. Osman INTI Common Stock Award 0.21% 50,000 23,554,985 01 Apr 2025 See Footnotes
Michael Allen Jerman INTI Common Stock Award 164.4% 50,000 80,411 01 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.